What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?

Research output: Contribution to journalReviewResearchpeer-review

Alba Gonzalez-Franquesa, Alison M Burkart, Elvira Isganaitis, Mary-Elizabeth Patti

Type 2 diabetes (T2D) is increasing worldwide, making identification of biomarkers for detection, staging, and effective prevention strategies an especially critical scientific and medical goal. Fortunately, advances in metabolomics techniques, together with improvements in bioinformatics and mathematical modeling approaches, have provided the scientific community with new tools to describe the T2D metabolome. The metabolomics signatures associated with T2D and obesity include increased levels of lactate, glycolytic intermediates, branched-chain and aromatic amino acids, and long-chain fatty acids. Conversely, tricarboxylic acid cycle intermediates, betaine, and other metabolites decrease. Future studies will be required to fully integrate these and other findings into our understanding of diabetes pathophysiology and to identify biomarkers of disease risk, stage, and responsiveness to specific treatments.

Original languageEnglish
Article number74
JournalCurrent Diabetes Reports
Issue number8
Publication statusPublished - Aug 2016
Externally publishedYes

    Research areas

  • Diabetes Mellitus, Type 2, Environment, Genome, Humans, Metabolome, Metabolomics, Risk Factors, Journal Article, Review

ID: 184415033